Full House star Dave Coulier revealed Wednesday that he’s been diagnosed with Stage 3 non-Hodgkin lymphoma. The actor and ...

Full House” star Dave Coulier revealed on Wednesday that he has been diagnosed with Stage 3 non-Hodgkin lymphoma, a form of ...

"Full House" stars and friends John Stamos and Dave Coulier 's bond is as strong as ever. This was made apparent after ...

Stamos and Coulier starred alongside each other on Full House for nine years. As Jesse Katsopolis and Joey Gladstone, the ...

As an additional tidbit for Full House fans that isn’t quite so downbeat: Dave Coulier revealed in the latest episode of Full ...

The cast of Full House became a tight-knit family after starring on the sitcom for eight seasons from 1987 to 1995. The ...

John Stamos will always be a hand for Dave Coulier to hold onto. That’s the pledge he made to his Full House costar, who revealed his stage 3 Non-Hodgkin's lymphoma diagnosis during the Nov. 13 ...

The less-than-family-friendly season 1 episode was “a disaster,” according to ‘Full House’ producer Karen Miller John Russell is a Writer/Reporter at PEOPLE. He joined the PEOPLE team in 2024.

The Post’s Zach Braziller looks at the top five St. John’s games to watch in the ... game that should have high intensity, a full house and plenty of interest. Richmond will undoubtedly ...

I’ve gotten to pee inside the “Full House” house, in San Francisco, which is a goal I never thought I had. We tried to pitch it as a TV show, and no one wanted it. They thought there wasn ...

Aprea Therapeutics, Inc. (APRE) came out with a quarterly loss of $0.64 per share versus the Zacks Consensus Estimate of a loss of $0.75. This compares to loss of $0.86 per share a year ago.

Net loss: US$3.78m (loss widened by 18% from 3Q 2023). US$0.64 loss per share. Revenue exceeded analyst estimates by 136%. Earnings per share (EPS) also surpassed analyst estimates by 20%. Looking ...